New patent on Hexvix granted in US

07-Nov-2007

PhotoCure has received a notification from the United States Patent and Trademark Office stating that a patent application for Hexvix in the US has been granted. The new patent is valid until 2019 and extends the current patent protection for Hexvix in the US by 3 years.

President and CEO, Kjetil Hestdal says in a comment: "We are very pleased to see this result of our continuous commitment to strengthen our intellectual property of existing and new products. This broadening and extension of current patent protection of Hexvix in US is a major contribution to secure the success of Hexvix."

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances